UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000035003
Receipt No. R000039903
Official scientific title of the study Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with multiple myeloma (prospective observational study)
Date of disclosure of the study information 2018/12/15
Last modified on 2018/12/27 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with multiple myeloma (prospective observational study)
Title of the study (Brief title) Observational study of the correlation between the geriatric assessment tools and prognosis of the geriatric patients with multiple myeloma (prospective observational study)
Region
Japan

Condition
Condition multiple myeloma
Classification by specialty
Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 We confirm whether the geriatric assessment tool can be multiple myeloma patients prognostic prediction
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes 5 years survival rate stratified by geriatric assessment tool
Key secondary outcomes monthly hospital days stratified by geriatric assessment tool
decrease rate of the score of EQ-5D-5L stratified by geriatric assessment tool
remission rate by treatment intensity stratified by geriatric assessment tool
survival rate by treatment intensity stratified by geriatric assessment tool

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
65 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 65 years of age or older
patients diagnosed with multiple myeloma
patients who got written informed consent
Key exclusion criteria patients who treat chemotherapy for hematological malignancy
Target sample size 80

Research contact person
Name of lead principal investigator Suyama Takuya
Organization Hitachi general hospital
Division name hematology,oncology
Address 2-1-1 Jonan-cho,Hitachi City,Ibaraki prefecture
TEL 0294231111
Email sutaku2468@yahoo.co.jp

Public contact
Name of contact person Suyama Takuya
Organization Hitachi general hospital
Division name hematology,oncology
Address 2-1-1 Jonan-cho,Hitachi City,Ibaraki prefecture
TEL 0294231111
Homepage URL
Email sutaku2468@yahoo.co.jp

Sponsor
Institute Hitachi general hospital
Institute
Department

Funding Source
Organization Hitachi general hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 日立総合病院(茨城県)

Other administrative information
Date of disclosure of the study information
2018 Year 12 Month 15 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2018 Year 11 Month 27 Day
Anticipated trial start date
2018 Year 12 Month 15 Day
Last follow-up date
2031 Year 12 Month 14 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information observational study
all patients who met the selection criteria in patients who visited our hospital forom December 2018 to December 2026
Items to be measured:age,sex,PS,G8,R-ISS, Charlson comobidity index,EQ-5D-5L(registration,Half a year, 1 year, 2 year, 3 year, 4 year, 5 year),serum Alb,hospital days,Chemotherapy, treatment effect, presence or absence of relapse, survival date, date of death

Management information
Registered date
2018 Year 11 Month 26 Day
Last modified on
2018 Year 12 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039903